It promotes insulin-sensitizing, fat-burning, and anti-atherosclerotic actions, thereby effectively counteracting several metabolic disorders, including type 2 diabetes, obesity, and cardiovascular diseases. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.